1 – 10 of 97
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer
(
- Contribution to journal › Article
-
Mark
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer : Working Group 3: Subcategorization of T1 Bladder Cancer
(
- Contribution to journal › Article
-
Mark
Cumulative incidence of and risk factors for BCG infection after adjuvant BCG instillations
2024) In BJU International(
- Contribution to journal › Article
-
Mark
Risk of prostate cancer death in men diagnosed with prostate cancer at cystoprostat-ectomy. A nationwide population-based study
(
- Contribution to journal › Article
-
Mark
Cystectomy for bladder cancer in Sweden - short-term outcomes after centralization
(
- Contribution to journal › Article
- 2023
-
Mark
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
(
- Contribution to journal › Article
-
Mark
Health-related quality of life prior to and 1 year after radical cystectomy evaluated with FACT-G and FACT-VCI questionnaires
(
- Contribution to journal › Article
-
Mark
Re : Alexander Cox, Niklas Klümper, Johannes Stein, et al. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2023.03.020
(
- Contribution to journal › Letter
-
Mark
What is a Bladder Cancer Molecular Subtype?
(
- Contribution to journal › Scientific review
-
Mark
Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer : Time To Reconsider the Evidence and Open the Quinolone Box?
2023) In European Urology Focus(
- Contribution to journal › Scientific review